
Amroltop 0.25% Cream
Manufacturer
Yash Pharma Laboratories Pvt Ltd
Salt Composition
Amorolfine (0.25% w/w)
Key Information
Short Description
Amroltop 0.25% Cream is an antifungal medication used for treating fungal infections of the nails.
Dosage Form
Cream
Introduction
Amroltop 0.25% Cream should be used in the dose and duration as advised by your doctor. Some of the common side effects include blisters on the skin, nail disorders like nail damage and discoloration, skin irritation, rash, or redness on the site of application. Please consult your doctor if these side effects persist for a longer duration. Make sure you wash your hands before and after applying the medicine. Avoid direct contact with the cream or ointment with your eyes. In case of direct contact, wash your eyes with water and seek immediate medical attention.
Directions for Use
This medicine is for external use only. Use it in the dose and duration as advised by your doctor. Check the label for directions before use. Clean and dry the affected area and apply the cream. Wash your hands after applying, unless hands are the affected area.
Safety Information
Side Effects
Blisters on the skin Nail disorders like nail damage and discoloration Skin irritation Rash Redness on the site of application
Alcohol Warning
No interaction found/established
Breastfeeding Warning
Amroltop 0.25% Cream should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
Pregnancy Warning
Information regarding the use of Amroltop 0.25% Cream during pregnancy is not available. Please consult your doctor.
How it works
Amroltop 0.25% Cream belongs to a class of anti-fungal medications. It inhibits the enzymes that are essential for fungal growth, thereby killing a wide variety of sensitive fungi.
Quick Tips
Amroltop 0.25% Cream helps treat fungal nail infections. Avoid getting it in your eyes, ears, nose, or mouth. If this happens, rinse with water immediately. Avoid the use of nail varnishes and artificial nails. Do not share your nail-filer to prevent the spread of infection. Do not use it if you are pregnant or breastfeeding. Keep using Amroltop 0.25% Cream for 3 to 5 days after the symptoms of the infection have cleared up to prevent it from coming back.
Related Medicines

Amrolstar Cream

Amrosys 0.25% Cream

Fintop-AF Cream

Livafin Cream

Amotru-XL Cream

Amtris Cream

Tcris Cream

Amrobest Cream

Amrolix 0.25% Cream

Geneefin-AF Cream
Frequently asked questions
How often should you use Amroltop 0.25% Cream?
Amroltop 0.25% Cream contains amorolfine, an antifungal medicine, used to treat fungal infections of the nails. It is applied once weekly on the affected finger or toenail. Your physician may advise applying it twice weekly in some cases. Clean and dry the affected area thoroughly before applying the cream. Do not stop treatment prematurely even if symptoms improve. Your doctor will recommend the exact dose and duration of treatment based on the type of fungal infection.
Is Amroltop 0.25% Cream a steroid?
No, Amroltop 0.25% Cream is not a steroid. It contains amorolfine, an antifungal medication used to treat fungal infections of the nails. It should only be used on the affected nails and skin.
Can we apply Amroltop 0.25% Cream on other parts of the body?
No, this medicine should not be applied to other areas of the body such as the eyes, mouth, or vagina. Use it only on the affected nails and skin. Before using the medication, consult your physician and follow instructions carefully.
Can Amroltop 0.25% Cream cause any local reactions or rashes?
Yes, there is a possibility of allergic reactions while using Amroltop 0.25% Cream, although the likelihood is unknown. These reactions are typically not common and may occur in individuals who are more sensitive to the medication. If you experience any skin reactions, contact your doctor immediately.
Is Amroltop 0.25% Cream safe to use in kids?
No, Amroltop 0.25% Cream should not be used on children or infants. There is a lack of evidence available to support its safety for this age group.